Nalls Sherbakoff Group, LLC Gsk PLC Call Options Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GSK
# of Institutions
20Shares Held
176KCall Options Held
0Put Options Held
0-
Boenning & Scattergood, Inc.43.3KShares$1.45 Million0.3% of portfolio
-
Altium Wealth Management LLC33.4KShares$1.12 Million0.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA20KShares$671,5630.06% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL18.6KShares$625,2960.0% of portfolio
-
Loveless Wealth Management LLC15KShares$504,3360.43% of portfolio
About GSK PLC
- Ticker GSK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,033,689,984
- Market Cap $68.3B
- Description
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...